BNTC – benitec biopharma inc. (US:NASDAQ)
Stock Stats
News
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Benitec Biopharma to Participate in Upcoming Conferences in March
Form 4 Benitec Biopharma Inc. For: Mar 31 Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Form 8-K Benitec Biopharma Inc. For: Mar 26
Form 4 Benitec Biopharma Inc. For: Mar 26 Filed by: Averill Madison Master Fund, Ltd.
Form SCHEDULE 13D/A Benitec Biopharma Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Form 8-K Benitec Biopharma Inc. For: Mar 26
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.